Allergan, Inc. v. Watson Laboratories, Inc., No. 12-1310 (Fed. Cir. June 18, 2012)

NOTE: This disposition is nonprecedential. Wniteb $>tates (!Court of ~ppeaIs

for tbe jfeberaI (!Circuit

ALLERGAN, INC., ALLERGAN USA, INC.,

ALLERGAN SALES, LLC, ENDO

PHARMACEUTICALS SOLUTIONS, INC., and SUPERNUS PHARMACEUTICALS, INC.,

Plaintiffs-Appellants,

v.

WATSON LABORATORIES, INC. - FLORIDA,

Defendant-Appellee,

and

SANDOZ, INC.,

Defendant-Appellee,

and

PADDOCK LABORATORIES, INC.,

Defendant-Appellee.

2012-1310

Appeal from the United States District Court for the District of Delaware in No. 09-CV-0511, Chief Judge Gregory M. Sleet.

JUDGMENT

2Juanita R. Brooks, Fish & Richardson P.C., of Minneapolis, Minnesota, argued for plaintiffs-appellants. With her on the brief were Jonathan E. Singer, of Minneapolis, Minnesota; and W. Chad Shear, of Wilmington, Delaware.

Charles A. Weiss, Kenyon & Kenyon, LLP, of New York, New York, argued for defendant-appellee, Watson Laboratories, Inc. - Florida. With him on the brief were Cynthia Lambert Hardman; and John W. Bateman, of Washington, DC.

Brian M. Kramer, Morrison & Foerster, LLP, of San Diego, California, argued for defendant-appellee, Sandoz, Inc. With him on the brief were David C. Doyle and Anders T. Aannestad; and Deanne E. Maynard of Washington, DC,

Wendy M. Ward, Merchant & Gould, P.C., of Madison, Wisconsin, argued for defendant-appellee, Paddock Laboratories, Inc. With her on the brief were Jeffrey S. Ward and Shane A. Brunner; and Rachel K. Zimmerman, of Minneapolis, Minnesota.

THIS CAUSE having been heard and considered, it is ORDERED and ADJUDGED: